Aphasia Clinical Trial - Effect of Stimulation of the Prefrontal Cortex on

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate whether transcranial direct current stimulation (tDCS) of the prefrontal cortex (PFC) influences lexical access and language production. The experimental paradigm will assess the impact of prefrontal stimulation by tDCS versus sham tDCS (S-tDCS) over the PFC of patients with chronic post-stroke aphasia during three language production tasks and a nonverbal executive functions task.

Clinical Trial Description

Background:

Language processing is a complex brain function supported by a large network, including domain-specific language areas as well as domain-general cognitive-control networks (Friederici & Gierhan, 2013). Noninvasive brain stimulation, such as transcranial direct current stimulation (tDCS), is increasingly being used as a promising therapeutic tool for psychiatric and neurological diseases (Tortella et al., 2015; Flöel, 2014). In the language domain, several studies revealed that tDCS over languagespecific areas induces changes in cortical function that enhances the recovery of language abilities in patients with post-stroke aphasia (Torres, Drebing & Hamilton, 2013; Monti et al., 2013). Beneficial effects of tDCS have also been found for stimulation over more domain-general cognitive control regions. Although research on non-invasive brain stimulation and aphasia reveals promising results, studies investigating the modulation of cognitive control-networks on lexical access are rare. Given the importance of a successful interplay between prefrontal and domain-specific language areas, possible therapeutic effects of tDCS over the prefrontal cortex (PFC) in aphasia can be of high value for rehabilitation and basic research.

Procedure:

A planned total of 30 patients will be included. In a first visit, the severity of aphasia, the medical history as well as inclusion/exclusion criteria will be evaluated. After this visit, patients will undergo two tDCS sessions (one tDCS and one S-tDCS session) with a one week interval between the sessions. Each session consists of an online (during stimulation) and an offline assessment (within 30 minutes after stimulation). Three language tasks and a nonverbal executive function task will be conducted online as well as offline in each of the two sessions (tDCS and S-tDCS). ;

Study Design

Related Conditions & MeSH terms

Aphasia

Clinical Trial Details

NCT number	NCT02840370
Study type	Interventional
Source	University of Fribourg
Contact
Status	Completed
Phase	N/A
Start date	May 2016
Completion date	September 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03622411` - Tablet-based Aphasia Therapy in the Chronic Phase	N/A
Recruiting	`NCT03605381` - MORbidity PRevalence Estimate In StrokE
Recruiting	`NCT03929432` - Treatment Outcomes With tDCS in Post-Stroke Aphasia	N/A
Completed	`NCT03662295` - Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention
Completed	`NCT03679637` - Tablet-based Aphasia Therapy in the Acute Phase After Stroke	N/A
Completed	`NCT03550092` - Analysis of Brain Activity to Uncover Brain-behavior Relationships Related to Therapy Outcomes in Aphasia	N/A
Completed	`NCT03228264` - A Trial Investigating Telerehabilitation as an add-on to Face-to-face Speech and Language Therapy in Post-stroke Aphasia.	N/A
Suspended	`NCT04290988` - Circuitry Assessment and Reinforcement Training Effects on Recovery	N/A
Recruiting	`NCT05969548` - pBFS-guided cTBS at Different Doses for Aphasia After Stroke	N/A
Recruiting	`NCT04138940` - Modulating Intensity and Dosage of Aphasia Scripts	N/A
Terminated	`NCT02249819` - Evaluating Anodal tDCS Preceding Aphasia Therapy	Phase 1/Phase 2
Completed	`NCT01654029` - Patient Centred Communication Intervention	N/A
Completed	`NCT00843427` - fMRI of Language Recovery Following Stroke in Adults	N/A
Active, not recruiting	`NCT00227461` - Levetiracetam (Keppra) to Improve Chronic Aphasia in Post-stroke Patients.	Phase 1
Completed	`NCT03773419` - Improving Electronic Written Communication in Aphasia	N/A
Not yet recruiting	`NCT04142866` - Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia	N/A
Suspended	`NCT04048668` - tDCS to Treat Subacute Aphasia	N/A
Recruiting	`NCT04081207` - Using Augmentative & Alternative Communication to Promote Language Recovery for People With Post-Stroke Aphasia	N/A
Completed	`NCT02226796` - Transcranial Direct Stimulation (tDCS) and Behavioral Intervention in Aphasia	N/A
Completed	`NCT01163461` - Phonomotor Treatment of Word Retrieval Deficits in Individuals With Aphasia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Effect of Stimulation of the Prefrontal Cortex on Language Production in Aphasic Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms